bioQuad 两批次 OsteoDenx 补充剂胶囊被召回：含未申报牛奶成分、过敏者慎防
总部位于加州 Yorba Linda 的 bioQuad Life Sciences 公司召回两批次 OsteoDenx 膳食补充剂胶囊，原因是产品含有未在标签上申报的牛奶成分。美国食品药品监管局（FDA）11月13日发布了这则召回通告。
据通告，问题是 FDA 在例行检查中发现的：OsteoDenx 所含的乳铁蛋白源自牛奶，但产品标签未按规定申报牛奶这一主要过敏原。对牛奶过敏的消费者误食后可能出现严重甚至危及生命的过敏反应。被召回产品于2024年11月1日至2026年11月11日期间，经 bioquad.com 官网、Amazon 以及经销商渠道售出，Redwood City 的一家牙科诊所也有销售。
截至通告发布时，尚未收到与该产品有关的患病报告，公司已停止相关产品的分销。FDA 提醒，对牛奶过敏的消费者不要食用被召回批次的 OsteoDenx，应按通告所列方式处置或退货；其他消费者如出现过敏症状应及时就医。
（来源：美国食品药品监管局）
bioQuad Recalls Two Lots of OsteoDenx Supplement Capsules Over Undeclared Milk
bioQuad Life Sciences, based in Yorba Linda, California, is recalling two lots of its OsteoDenx dietary supplement capsules because they contain milk that was not declared on the label. The U.S. Food and Drug Administration (FDA) posted the recall announcement on November 13.
According to the notice, the problem surfaced during a routine FDA inspection: the lactoferrin in OsteoDenx is derived from milk, but the label does not declare milk, a major food allergen. Consumers with a milk allergy who eat the product risk a serious or life-threatening allergic reaction. The recalled capsules were sold between November 1, 2024 and November 11, 2026 through bioquad.com, Amazon and distributors, and were also sold at a dental office in Redwood City.
No illnesses related to the product had been reported as of the announcement, and distribution has been halted. The FDA advises consumers with a milk allergy not to consume the recalled lots and to dispose of or return the product as described in the notice, and to seek medical care if allergic symptoms occur.
(Source: U.S. Food and Drug Administration)
来源：美国食品药品监管局
发布：GSM·美国（发布链接）
图片来源：Wikimedia Commons：File:Omega 3 capsules in white bottle (52715127894).jpg（开放授权）
GSM Global · 本篇英文版 English edition of this story
